Positioning no disclosures inside 60 days, left as found
Options put/call open interest 3.61, read 2026-11-03
Ethical does not pass the values gate
Price79.38 USD
Fair value102.08
Ethical score70.0/100
Value readUndervaluedas of 6 Nov 2026
Our investment reviews on this name
2026-11-05Read Distribution82.41-3.7% to today ✓Markdown gives way to Distribution after a 15% slide in 3 weeks
2026-10-15Read Markdown96.52-17.8% to today ✓Accumulation gives way to Markdown first Markdown read since September
2026-10-02Read Accumulation96.38-17.6% to today Markdown gives way to Accumulation
2026-09-13Read Markdown100.93-21.4% to today ✓Markup gives way to Markdown after a 10% rise in 10 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
SkyWest, Inc. holds its Distribution at $79.38. Elevated stress, defensive posture warranted, held for 1 days.
As held on the ledger · 2026-11-06
Phase
Distribution · caution
Quantitative state
Elevated stress, defensive posture warranted, held for 1 days
Price at the screen
$79.38
Valuation
8.38 trailing · 7.68 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.61
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
33.50%
Below 33%
Interest-bearing debt is 33.5% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
7.91%
Below 33%
Cash held in interest-bearing accounts and securities is 7.9% of assets, under the one-third limit.
Pass
Receivables
3.82%
Below 49%
Money owed to the company is 3.8% of assets, under the 49% limit.
Pass
Revenue purity
1.07%
Below 5%
Only 1.1% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
SkyWest,'s business is in a permissible area, but its interest-bearing debt is about 33% of the company, just over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when SKYW's ethical verdict changes
Today SKYW does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 6 Nov 2026: it trades at roughly a 22% discount to our $102.08 fair value, 6.40% revenue growth.
Fair value range in USD, drawn from the 2026-11-06 screen. The gold marker is the market price at the same screen. A 22.2% discount to the base estimate.
Where our models see it going: fair-value estimate $102.08, with a range of $94.50 to $117.39, dated to the 2026-11-06 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Cheap multiple on regional airline signals cycle trap
Think of SkyWest as the scheduled bus for the skies, shuttling passengers on routes the big carriers ignore. The forward multiple of 8.1 times earnings, 7 percent revenue growth and 16 percent return on equity look solid on paper, yet the opportunity rating is none. This is a cyclical industry where current margins near 10 percent can compress sharply when fuel costs rise or travel demand falls.
Analysts see upside to 122 dollars and the ethical screen is clear, but those factors do not change the core issue. Peak earnings in a good year often produce the lowest multiples, and what looks like value is frequently just the start of the next downturn.
Risk sits in the airline cycle itself, with exposure to fuel prices, labour costs and economic slowdowns that can erase profits faster than any lease book can offset. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
SKYW trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 11.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (6 analysts) rates it none, with a mean price target of $122. Since the last review it its composite score eased.
2026-10-29Markdown$93.03+0.7%Entry 15
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (6 analysts) rates it none, with a mean price target of $122. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Markdown$92.35+0.0%Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (6 analysts) rates it none, with a mean price target of $122. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Markdown$92.35+0.0%Entry 13
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (6 analysts) rates it none, with a mean price target of $122. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Markdown$92.35+0.0%Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (6 analysts) rates it none, with a mean price target of $122. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Markdown$92.35+0.0%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading oversold. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (6 analysts) rates it none, with a mean price target of $122. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Markdown$92.35+0.0%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading oversold. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (6 analysts) rates it none, with a mean price target of $122. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Markdown$92.35+0.0%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading oversold. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (6 analysts) rates it none, with a mean price target of $122. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Markdown$92.35-4.3%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading oversold. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (6 analysts) rates it none, with a mean price target of $122. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-15Markdown · changed$96.52+0.1%Entry 7
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (6 analysts) rates it none, with a mean price target of $122.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
